AGP Picks
View all

The latest health and wellness news from Maryland

Provided by AGP

Got News to Share?

Techcyte parasitology study heads to APHL 2026

May 4, 2026
Techcyte parasitology study heads to APHL 2026

By AI, Created 11:29 AM UTC, May 20, 2026, /AGP/ – Techcyte said a Contra Costa County Public Health Laboratory validation of its AI-assisted ova and parasite workflow was accepted for presentation at the APHL 2026 Annual Conference in Baltimore. The study reports 97% accuracy and suggests digital screening could help public health labs manage higher volumes and staffing pressure.

Why it matters: - Ova and parasite testing still depends heavily on manual microscopy, specialized expertise, and long training cycles. - Public health labs facing higher specimen volumes and staffing constraints could use AI-assisted workflows to speed screening without replacing traditional confirmation steps. - The validation adds another data point for AI use in parasitology, a workflow area where efficiency gains can affect turnaround time and staff workload.

What happened: - Contra Costa County Public Health Laboratory conducted a validation study of Techcyte’s AI-assisted ova and parasite workflow. - The study was accepted for presentation at the APHL 2026 Annual Conference in Baltimore, May 4-7, 2026. - The poster will be made publicly available after the conference on APHL’s website. - Techcyte will exhibit at APHL 2026 at Booth 201.

The details: - The study is titled “Validation of the Techcyte/Pramana Platform for the Detection of Parasites in Stool Specimens in a County Public Health Laboratory.” - The evaluation used Techcyte’s parasitology suite with trichrome and wet mount solutions. - The workflow paired Techcyte software with an automated whole slide imager from Pramana, now Evident. - CCPHL analyzed 549 cases, defined as patient samples with paired trichrome and wet mount slides. - The study reported 97% accuracy, 98% sensitivity, and 97% specificity. - The validation included both newly received patient specimens and archived cases. - Results were compared with traditional microscopy methods. - CCPHL implemented the platform into its workflow in January 2026. - The lab reported measurable reductions in turnaround time, along with workflow efficiency gains and less staff fatigue. - Final confirmation of positive cases continued to be performed with traditional light microscopy. - Techcyte’s parasitology solution also supports modified acid-fast staining within a unified workflow. - Techcyte said its platform is designed to support multiple staining methods for public health laboratory use.

Between the lines: - The study suggests AI can fit into existing public health lab practice without forcing a full replacement of manual review. - The continued use of light microscopy for final confirmation points to a hybrid model, not full automation. - Techcyte is using the APHL conference to show third-party validation rather than only product claims. - The announcement includes a standard research-use-only notice for Techcyte’s anatomic and clinical pathology platform in the United States.

What’s next: - APHL attendees can review the poster during the conference and online afterward. - Techcyte is positioning the platform for broader adoption in public health laboratories that need faster parasitology workflows. - The company’s conference presence may help convert validation results into further lab interest and potential implementations.

The bottom line: - Techcyte is betting that AI-assisted parasitology can improve lab throughput while preserving traditional diagnostic safeguards.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Maryland Healthcare Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share us

on your social networks:

Sign up for:

Maryland Healthcare Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.